Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Studies that have evaluated the use of intravenous vitamin C in adults with sepsis who were receiving vasopressor therapy in the intensive care unit (ICU) have shown mixed results with respect to the risk of death and organ dysfunction. METHODS: In this randomized, placebo-controlled trial, we assigned adults who had been in the ICU for no longer than 24 hours, who had proven or suspected infection as the main diagnosis, and who were receiving a vasopressor to receive an infusion of either vitamin C (at a dose of 50 mg per kilogram of body weight) or matched placebo administered every 6 hours for up to 96 hours. The primary outcome was a composite of death or persistent organ dysfunction (defined by the use of vasopressors, invasive mechanical ventilation, or new renal-replacement therapy) on day 28. RESULTS: A total of 872 patients underwent randomization (435 to the vitamin C group and 437 to the control group). The primary outcome occurred in 191 of 429 patients (44.5%) in the vitamin C group and in 167 of 434 patients (38.5%) in the control group (risk ratio, 1.21; 95% confidence interval [CI], 1.04 to 1.40; P = 0.01). At 28 days, death had occurred in 152 of 429 patients (35.4%) in the vitamin C group and in 137 of 434 patients (31.6%) in the placebo group (risk ratio, 1.17; 95% CI, 0.98 to 1.40) and persistent organ dysfunction in 39 of 429 patients (9.1%) and 30 of 434 patients (6.9%), respectively (risk ratio, 1.30; 95% CI, 0.83 to 2.05). Findings were similar in the two groups regarding organ-dysfunction scores, biomarkers, 6-month survival, health-related quality of life, stage 3 acute kidney injury, and hypoglycemic episodes. In the vitamin C group, one patient had a severe hypoglycemic episode and another had a serious anaphylaxis event. CONCLUSIONS: In adults with sepsis receiving vasopressor therapy in the ICU, those who received intravenous vitamin C had a higher risk of death or persistent organ dysfunction at 28 days than those who received placebo. (Funded by the Lotte and John Hecht Memorial Foundation; LOVIT ClinicalTrials.gov number, NCT03680274.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A systematic review and meta-analysis of 2124 patients, with 1274 on pulmonary hypertension specific agents demonstrated only small quality of life benefits in patients with PH and IPF, thus there is insufficient evidence to support their widespread use [119].”
From Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF) (2024) · cites this paper as [119]
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Self-citationAPACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795
A global clinical measure of fitness and frailty in elderly people
Rockwood, K. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.050051 · Cited by 8,968
Rudd, K. E., Johnson, S. C., Agesa, K. M., Shackelford, K. A., Tsoi, D., Kievlan, D. R., Colombara, D. V., Ikuta, K. S., Kissoon, N., Finfer, S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32989-7 · Cited by 7,971
Hospital Deaths in Patients With Sepsis From 2 Independent Cohorts
Liu, V., Escobar, G. J., Greene, J. D., Soule, J., Whippy, A., Angus, D. C., & Iwashyna, T. J. (2014) · JAMA · doi:10.1001/jama.2014.5804 · Cited by 977
A Randomized Trial of Glutamine and Antioxidants in Critically Ill Patients
Heyland, D., Muscedere, J., Wischmeyer, P. E., Cook, D., Jones, G., Albert, M., Elke, G., Berger, M. M., & Day, A. G. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212722 · Cited by 904
Self-citationHydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock
Marik, P. E., Khangoora, V., Rivera, R., Hooper, M. H., & Catravas, J. (2017) · Chest · doi:10.1016/j.chest.2016.11.036 · Cited by 887
Fowler, A. A., Truwit, J. D., Hite, R. D., Morris, P. E., DeWilde, C., Priday, A., Fisher, B., Thacker, L. R., Natarajan, R., Brophy, D. F., et al. (2019) · JAMA · doi:10.1001/jama.2019.11825 · Cited by 836
Research works printed but not linked: 1
- Kellum JA, Lameire N, Aspelin P, et al. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012;2:Suppl 1:1-38.
Cited by
ESPEN practical and partially revised guideline: Clinical nutrition in the intensive care unit
Singer, P., Blaser, A. R., Berger, M. M., Calder, P. C., Casaer, M., Hiesmayr, M., Mayer, K., Montejo-Gonzalez, J. C., Pichard, C., Preiser, J.-C., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.07.011 · Cited by 793
Vincent, J.-L. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2022.104318 · Cited by 208
Therapeutic advances in COVID-19
Murakami, N., Hayden, R., Hills, T. E., Al-Samkari, H. T., Casey, J. D., Sorbo, L. D., Lawler, P. R., Sise, M. E., & Leaf, D. E. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00642-4 · Cited by 174
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Intensive Care Medicine · doi:10.1007/s00134-026-08361-1 · Cited by 141
Self-citationTargeting the host response in sepsis: current approaches and future evidence
Bode, C., Weis, S., Sauer, A., Wendel‐Garcia, P. D., & David, S. (2023) · Critical Care · doi:10.1186/s13054-023-04762-6 · Cited by 139
“The LOVIT trial, an RCT including patients with septic shock, found that vitamin C therapy increased the risk of a composite end point-death or persistent organ dysfunction at day 28 [42].”
MethodSurviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007075 · Cited by 117
Self-citationGharamti, A. A., Samara, O., Monzon, A., Montalbano, G. E., Scherger, S. J., DeSanto, K., Chastain, D. B., Sillau, S., Montoya, J. G., Franco‐Paredes, C., et al. (2022) · Cytokine · doi:10.1016/j.cyto.2022.156006 · Cited by 118
Liu, S., Yao, C., Xie, J., Liu, H., Wang, H., Lin, Z., Qin, B., Wang, D., Lü, W., Ma, X., et al. (2023) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.0780 · Cited by 118
Exploring the role of antioxidants in sepsis-associated oxidative stress: a comprehensive review
Sahoo, D. K., Wong, D. M., Patani, A., Paital, B., Yadav, V. K., Patel, A., & Jergens, A. E. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1348713 · Cited by 107
Towards personalized medicine: a scoping review of immunotherapy in sepsis
Slim, M. A., van Mourik, N., Bakkerus, L., Fuller, K., Acharya, L. S., Giannidis, T., Dionne, J. C., Oczkowski, S. J. W., Netea, M. G., Pickkers, P., et al. (2024) · Critical Care · doi:10.1186/s13054-024-04964-6 · Cited by 96
“In an RCT in sepsis patients receiving vasopressors those who received intravenous vitamin C had a higher risk of death or persistent organ dysfunction (44.5% vs 38.5%, n = 872) [51].”
BackgroundInfluentialPediatric Sepsis Diagnosis, Management, and Sub-phenotypes
Weiss, S. L., & Fitzgerald, J. C. (2023) · PEDIATRICS · doi:10.1542/peds.2023-062967 · Cited by 100
Surviving Sepsis Campaign Guidelines 2021: highlights for the practicing clinician
Oczkowski, S. J. W., Alshamsi, F. E., Belley‐Côté, E. P., Centofanti, J., Møller, M. H., Nunnally, M., & Alhazzani, W. A. (2022) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16290 · Cited by 123
The End of “One Size Fits All” Sepsis Therapies: Toward an Individualized Approach
Vincent, J., van der Poll, T., & Marshall, J. C. (2022) · Biomedicines · doi:10.3390/biomedicines10092260 · Cited by 91
“Nitric oxide inhibitors/scavengers [41,42] Vitamins [43]”
Iba, T., Maier, C. L., Helms, J., Ferrer, R., Thachil, J. V., & Levy, J. H. (2024) · Annals of Intensive Care · doi:10.1186/s13613-024-01301-6 · Cited by 86
ESPEN practical short micronutrient guideline
Berger, M. M., Shenkin, A., Dizdar, O. S., Amrein, K., Augsburger, M. P., Biesalski, H. K., Bischoff, S. C., Casaer, M. P., Gündoğan, K., Lepp, H.-L., et al. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.01.030 · Cited by 93
Redox signaling in innate immunity and inflammation: focus on macrophages and neutrophils
Braunstein, I., Motohashi, H., Dallenga, T. K., Schaible, U. E., & Benhar, M. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.06.006 · Cited by 79
Ltaief, Z., Ben‐Hamouda, N., Rancati, V., Gunga, Z., Marcucci, C., Kirsch, M. E. W., & Liaudet, L. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11216407 · Cited by 86
History of scurvy and use of vitamin C in critical illness: A narrative review
Dresen, E., Lee, Z., Hill, A., Notz, Q., Patel, J. J., & Stoppe, C. (2022) · Nutrition in Clinical Practice · doi:10.1002/ncp.10914 · Cited by 78
Lyu, Q., Zheng, R., Chen, Q., Yu, J., Shao, J., & Gu, X. (2022) · Critical Care · doi:10.1186/s13054-022-04175-x · Cited by 63
Oxidative Stress and Cerebral Vascular Tone: The Role of Reactive Oxygen and Nitrogen Species
Salvagno, M., Sterchele, E. D., Zaccarelli, M., Mrakic‐Sposta, S., Welsby, I. J., Balestra, C., & Taccone, F. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25053007 · Cited by 67
“Nevertheless, they have been shown to be ineffective in a clinical study of sepsis [178].”
BackgroundVitamin C Supplementation for the Treatment of COVID-19: A Systematic Review and Meta-Analysis
Olczak-Pruc, M., Świeczkowski, D., Ładny, J. R., Pruc, M., Juárez‐Vela, R., Rafique, Z., Peacock, W. F., & Szarpak, Ł. (2022) · Nutrients · doi:10.3390/nu14194217 · Cited by 64
“In addition, similar observations were seen in a study that aimed to evaluate the use of intravenous vitamin C in adults with sepsis who were receiving vasopressor therapy in the intensive care unit (ICU) [51].”
BackgroundThe LOVIT-COVID Investigators, O. B. O. T. C. C. C. T. G., Florescu, S., Stanciu, D., Zaharia, M., Kosa, A., Codreanu, D., Fareed, K., Kidwai, A., Kaye, C., Coutts, A., et al. (2023) · JAMA · doi:10.1001/jama.2023.21407 · Cited by 55
Self-citationNutritional Support in the ICU
Reignier, J., Rice, T. W., Arabi, Y. M., & Casaer, M. P. (2025) · BMJ · doi:10.1136/bmj-2023-077979 · Cited by 80
“…and promising results of pilot clinical trials, corrective interventions were either not beneficial or detrimental in adequately powered RCTs. 18 59-62 These unexpected results suggest that either serum levels are unreliable for assessing deficiencies or the reduced levels are adaptive during…”
Self-citationManagement of Sepsis and Septic Shock: What Have We Learned in the Last Two Decades?
Kamath, S., Altaq, H. H., & Abdo, T. (2023) · Microorganisms · doi:10.3390/microorganisms11092231 · Cited by 68
“After these guidelines, two randomized controlled trials were published: VICTAS in 2021, showing no difference in mortality, and LOVIT (largest RCT for vitamin C in sepsis; n = 872) in 2022, showing a higher risk of death or persistent organ dysfunction at 28 days in the vitamin C group [196,197].”
MethodReignier, J., Roux, B. G., Dequin, P. F., Maluf, V. A. B., Bohé, J., Casaer, M. P., Delbove, A., Dupuis, C., Fontaine, E. M., Gamon, P., et al. (2025) · Annals of Intensive Care · doi:10.1186/s13613-025-01509-0 · Cited by 64
“More recently, a metabolic equation specifically designed for critically ill children, which requires accurate measurement of carbon dioxide production, has been reported [207].”
Pitre, T., Drover, K., Chaudhuri, D., Zeraaktkar, D., Menon, K., Gershengorn, H. B., Jayaprakash, N., Spencer-Segal, J. L., Pastores, S. M., Nei, A. M., et al. (2024) · Critical Care Explorations · doi:10.1097/cce.0000000000001000 · Cited by 60
Self-citationThe Japanese Critical Care Nutrition Guideline 2024
Nakamura, K., Yamamoto, R., Higashibeppu, N., Yoshida, M., Tatsumi, H., Shimizu, Y., Izumino, H., Oshima, T., Hatakeyama, J., Ouchi, A., et al. (2025) · Journal of Intensive Care · doi:10.1186/s40560-025-00785-z · Cited by 58
Mottale, R., Dupuis, C., Szklarzewska, S., & Preiser, J. (2025) · Annals of Intensive Care · doi:10.1186/s13613-025-01588-z · Cited by 56
Lykkesfeldt, J., Carr, A. C., & Tveden‐Nyborg, P. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100043 · Cited by 54
Medical nutrition therapy in patients receiving ECMO: Evidence‐based guidance for clinical practice
Dresen, E., Naidoo, O., Hill, A., Elke, G., Lindner, M., Jonckheer, J., Waele, E. D., Meybohm, P., Modir, R., Patel, J. J., et al. (2022) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.2467 · Cited by 49
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Shime, N., Nakada, T.-A., Yatabe, T., Yamakawa, K., Aoki, Y., Inoue, S., Iba, T., Ogura, H., Kawai, Y., Kawaguchi, A., et al. (2025) · Journal of Intensive Care · doi:10.1186/s40560-025-00776-0 · Cited by 52
Parenteral Vitamin C in Patients with Severe Infection: A Systematic Review
Agarwal, A., Basmaji, J., Fernando, S. M., Ge, F. Z., Xiao, Y., Faisal, H., Honarmand, K., Hylands, M., Lau, V. I., Lewis, K. A., et al. (2022) · NEJM Evidence · doi:10.1056/evidoa2200105 · Cited by 48
Self-citationWare, L. B., Files, D. C., Fowler, A., Aboodi, M. S., Aggarwal, N. R., Brower, R. G., Chang, S. Y., Douglas, I. S., Fields, S., Foulkes, A. S., et al. (2024) · JAMA · doi:10.1001/jama.2024.8772 · Cited by 45
The science of micronutrients in clinical practice – Report on the ESPEN symposium
Berger, M. M., Amrein, K., Barazzoni, R., Bindels, L. B., Lesmes, I. B., Calder, P. C., Cappa, S. F., Cuerda, C., D’Amelio, P., de Man, A., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.12.006 · Cited by 48
Üstündağ, H., Doğanay, S., Kalındemirtaş, F. D., Demir, Ö., Huyut, M. T., Kurt, N., Özgeriş, F. B., & Akbaba, Ö. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121875 · Cited by 47
Sidebotham, D. A., & Barlow, C. J. (2023) · Anaesthesia · doi:10.1111/anae.16161 · Cited by 40
“…Supporting Information Table S2. chance, it was used as part of the justi fi cation for the larger Lessening Organ dysfunction with VITamin C (LOVIT) trial, comparing the effect of high-dose vitamin C with placebo in patients whose lungs were mechanically ventilated as a result of sepsis [14].”
BackgroundMethodRoberson, S. W., Nwosu, S., Collar, E. M., Kiehl, A. L., Harrison, F. E., Bastarache, J. A., Wilson, J. E., Mart, M. F., Sevransky, J., Ely, E. W., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.0380 · Cited by 49
Liang, B., Su, J., Shao, H., Chen, H., & Xie, B. (2023) · Critical Care · doi:10.1186/s13054-023-04392-y · Cited by 43
“Seven studies [15, 24, 27, 29, 31, 35, 37] analyzed unclear patients.”
BackgroundInfluentialMoskowitz, A. L., Berg, K. M., Grossestreuer, A. V., Balaji, L., Liu, X., Cocchi, M. N., Chase, M., Gong, M. N., Gong, J. F., Parikh, S. M., et al. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202301-0034oc · Cited by 33
Renal perfusion pressure: role and implications in critical illness
Panwar, R., McNicholas, B., Teixeira, J. P., & Kansal, A. (2025) · Annals of Intensive Care · doi:10.1186/s13613-025-01535-y · Cited by 40
“Likewise, on the basis of observational studies, the antioxidant vitamin C was felt to have potential as a treatment in sepsis, but subsequent multicenter trials have shown no benefit or signals for harm [188–190].”
S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge – Update 2025
Brunkhorst, F. M., Adamzik, M., Axer, H., Bauer, M. W., Bode, C., Bone, H.-G., Brenner, T., Bucher, M., David, S., Dietrich, M., et al. (2025) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-025-01317-1 · Cited by 47
Toward Precision in Nutrition Therapy
Stoppe, C., Hill, A., Christopher, K. B., & Kristof, A. S. (2024) · Critical Care Medicine · doi:10.1097/ccm.0000000000006537 · Cited by 35
Hung, K., Chuang, M., Chen, J., Hsu, C., Chiu, C., Chang, Y.-J., Lee, C., Chen, I., & Sun, C. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1094757 · Cited by 31
“In contrast, a recent large-scale randomized controlled trial (RCTs) involving 872 patients with sepsis even reported a slight increase in the risk of mortality/persistent organ dysfunction at 28 days in those with IVVC monotherapy compared to those without (23).”
ResultInfluentialOxidative stress and acute pancreatitis (Review)
Cai, Y., Yang, F., & Huang, X. (2024) · Biomedical Reports · doi:10.3892/br.2024.1812 · Cited by 36
“…antioxidant in the body, vitamin C has shown favorable clinical efficacy for burns (78), acute and chronic pain (79), severe treatment, sepsis (80), ischemia‑reperfusion injury (81), blood pres‑ sure control (82), emotional improvement in hospitalized patients (83), and acute kidney disease…”
BackgroundUnar, A., Bertolino, L., Patauner, F., Gallo, R., & Durante‐Mangoni, E. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12196128 · Cited by 31
“While several studies have shown potential advantages, others have discovered no substantial effect or even possible negative consequences [54,55].”
BackgroundCurrent perspectives in the management of sepsis and septic shock
Chiscano‐Camón, L., Ruiz‐Sanmartín, A., Bajaña, I., Bastidas, J., López‐Martínez, R., Franco‐Jarava, C., González‐López, J. J., Larrosa, N., Riera, J., Nuvials, X., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1431791 · Cited by 35
“However, a recent study conducted by Lamontagne et al. (83) has demonstrated that the administration of vitamin C in sepsis has detrimental effects, leading to an increase in morbidity and 28-day mortality.”
BackgroundHemilä, H., & Chalker, E. (2022) · European Journal of Clinical Nutrition · doi:10.1038/s41430-022-01254-8 · Cited by 32
“The published survival curves comparing the vitamin C and placebo groups of the LOVIT trial cover a period of 180 days [14].”
BackgroundMethodInfluentialVitamin C deficiency can lead to pulmonary hypertension: a systematic review of case reports
Hemilä, H., & de Man, A. (2024) · BMC Pulmonary Medicine · doi:10.1186/s12890-024-02941-x · Cited by 33
Potential Antioxidant Multitherapy against Complications Occurring in Sepsis
Abelli, J., Méndez-Valdés, G., Gómez-Hevia, F., Bragato, M. C., Chichiarelli, S., Saso, L., & Rodrigo, R. (2022) · Biomedicines · doi:10.3390/biomedicines10123088 · Cited by 32
“Indeed, other clinical trials have suggested an increased incidence of sepsis-induced AKI [68] and increased risk of mortality [74].”
BackgroundMohamed, A., Abdelaty, M. A., Saad, M. O., Shible, A. A., Mitwally, H., Akkari, A. M., Elbuzidi, A. A. S., Bintaher, A., Hashim, A., Abdelrahim, M., et al. (2023) · Shock · doi:10.1097/shk.0000000000002110 · Cited by 29
“The incidence of primary composite outcomes was significantly higher in the vitamin C group than in the placebo group (21).”
BackgroundMethodLee, Z., Ortiz‐Reyes, L., Lew, C. C. H., Hasan, M. S., Ke, L., Patel, J. J., Stoppe, C., & Heyland, D. K. (2023) · Annals of Intensive Care · doi:10.1186/s13613-023-01116-x · Cited by 31
“In studies that reported the SOFA score, we observed a trend towards lower SOFA scores at the 96th hour for the IVVC group (MD − 0.82, 95% CI -1.77, 0.14; p = 0.09; I2 = 63%; Additional file 1: Figure S29) [11, 19, 26, 41].”
BackgroundInfluentialSelf-citationWhat do we know about micronutrients in critically ill patients? A narrative review
de Man, A., Stoppe, C., Koekkoek, K. W. A. C., Briassoulis, G. C., Subasinghe, L., Cobilinschi, C., Deane, A. M., Manzanares, W., Grințescu, I. M., Mirea, L. E., et al. (2024) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.2700 · Cited by 33
“92 Some methodological limitations and challenges were identified in these studies, which may have been underrecognized, as well in other studies of MNs and will need more attention in future studies.”
Dresen, E., Notz, Q., Menger, J., Homayr, A. L., Lindner, M., Radke, D. I., Stoppe, C., & Elke, G. (2023) · Nutrition in Clinical Practice · doi:10.1002/ncp.10984 · Cited by 29
Yanase, F., Spano, S., Maeda, A., Chaba, A., Naorungroj, T., Ow, C. P. C., Lankadeva, Y. R., May, C. N., Betrie, A. H., Lane, D. J. R., et al. (2023) · Critical Care · doi:10.1186/s13054-023-04644-x · Cited by 27
“Randomized controlled trials, however, have shown variable results or even possible harm [10–12].”
BackgroundResultInfluentialIba, T., Helms, J., Maier, C. L., Ferrer, R., & Levy, J. H. (2025) · Inflammation Research · doi:10.1007/s00011-025-01994-w · Cited by 33
How We Escalate Vasopressor and Corticosteroid Therapy in Patients With Septic Shock
Teja, B. J., Bosch, N. A., & Walkey, A. J. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.09.019 · Cited by 33
Mironova, G. Y., Kowalewska, P. M., El‐Lakany, M. A., Tran, C. H. T., Sancho, M., Zechariah, A., Jackson, W. F., & Welsh, D. G. (2023) · Physiological Reviews · doi:10.1152/physrev.00035.2022 · Cited by 31
Schlapbach, L. J., Raman, S., Buckley, D. H. F., George, S., King, M., Ridolfi, R., Harley, A., Cree, M., Long, D. A., Erickson, S. J., et al. (2024) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000003346 · Cited by 25
Sae‐khow, K., Charoensappakit, A., Chiewchengchol, D., & Leelahavanichkul, A. (2022) · Biomedicines · doi:10.3390/biomedicines11010051 · Cited by 25
“Moreover, the LOVIT trial (vitamin C 50 mg/kg every 6 h for 4 days) [101] indicates that the patients who received intravenous vitamin C had a higher risk of death or persistent organ dysfunction at 28 days than those who received a placebo.”
BackgroundIV Vitamin C in Adults With Sepsis: A Bayesian Reanalysis of a Randomized Controlled Trial*
Angriman, F., Muttalib, F., Lamontagne, F., Adhikari, N. K. J., & LOVIT Investigators (2023) · Critical Care Medicine · doi:10.1097/ccm.0000000000005871 · Cited by 24
“cBased on a meta-analysis of 30-d mortality among published trials at low risk of bias, excluding reference (5).”
BackgroundMethodInfluentialSelf-citationElke, G., Hartl, W. H., Adolph, M., Angstwurm, M., Brunkhorst, F. M., Edel, A., de Heer, G., Felbinger, T. W., Goeters, C., Hill, A., et al. (2023) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-023-01001-2 · Cited by 23
Lin, Y., Alhaskawi, A., Chen, L., & Moqbel, S. A. A. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1695992 · Cited by 27
An update on essential micronutrients in critical illness
Koekkoek, K. W. A. C., & Berger, M. M. (2023) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001062 · Cited by 31
Rynne, J., Mosavie, M., Masse, M.-H., Ménard, J., Battista, M., Maslove, D. M., Sorbo, L. D., St-Arnaud, C., D’Aragon, F., Fox‐Robichaud, A., et al. (2025) · Intensive Care Medicine · doi:10.1007/s00134-024-07733-9 · Cited by 21
Self-citationAccounting for Competing Events When Evaluating Long-Term Outcomes in Survivors of Critical Illness
Angriman, F., Ferreyro, B. L., Harhay, M. O., Wunsch, H., Rosella, L. C., & Scales, D. C. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202305-0790cp · Cited by 21
Vitamin C for the common cold and pneumonia
Hemilä, H., & Chalker, E. (2025) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16926 · Cited by 202
Current role of high dose vitamin C in sepsis management: A concise review
Juneja, D., Nasa, P., & Jain, R. (2022) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v11.i6.349 · Cited by 30
Belousovienė, E., Pranskūnienė, Ž., Vaitkaitienė, E., Pilvinis, V., & Pranskūnas, A. (2023) · BMC Anesthesiology · doi:10.1186/s12871-023-02265-z · Cited by 22
“Potentially beneficial ascorbic acid’s role was challenged by a recently published LOVIT trial [51].”
BackgroundIV Vitamin C in Sepsis: A Latest Systematic Review and Meta-Analysis
Wen, C., Li, Y., Hu, Q., Liu, H., Xu, X., & Lü, M. (2023) · International Journal of Clinical Practice · doi:10.1155/2023/6733465 · Cited by 23
Safabakhsh, M., Imani, H., Shahinfar, H., Mohammadpour, M., Rohani, P., & Shab‐Bidar, S. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.03.030 · Cited by 19
Vasoplegia in Heart, Lung, or Liver Transplantation: A Narrative Review
Ortoleva, J. P., Dalia, A. A., Convissar, D. L., Pisano, D. V., Bittner, E. A., & Berra, L. M. (2025) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2025.01.012 · Cited by 18
Cell-Free Hemoglobin in the Pathophysiology of Trauma: A Scoping Review
Ross, J. T., Robles, A. J., Mazer, M. B., Studer, A., Remy, K. E., & Callcut, R. A. (2024) · Critical Care Explorations · doi:10.1097/cce.0000000000001052 · Cited by 33
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Shime, N., Nakada, T., Yatabe, T., Yamakawa, K., Aoki, Y., Inoue, S., Iba, T., Ogura, H., Kawai, Y., Kawaguchi, A., et al. (2025) · Acute Medicine & Surgery · doi:10.1002/ams2.70037 · Cited by 27
Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF)
Aribindi, K., Liu, G. Y., & Albertson, T. E. (2024) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2024.2396121 · Cited by 17
“Several other antioxidant compounds, such as Vitamin C, have been studied in sepsis and ARDS without significant improvement, and may even worsen outcomes [119,120].”
Intravenous vitamin C therapy in adult patients with sepsis: A rapid practice guideline
Blaser, A. R., Alhazzani, W. A., Belley‐Côté, E. P., Møller, M. H., Adhikari, N. K. J., Burry, L. D., Coopersmith, C. M., Duhailib, Z. A., Fujii, T., Granholm, A., et al. (2023) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.14311 · Cited by 22
“Moreover, the largest study published to date suggested harm from vitamin C in the composite outcome of death or persistent organ dysfunction.(11) Recent studies suggested that vitamin C may not attenuate oxidative stress in sepsis, as increased concentrations of vitamin C did not lead to any changes in oxidative stre…”
Self-citationAn update of the effects of vitamins D and C in critical illness
Hill, A., Starchl, C., Dresen, E., Stoppe, C., & Amrein, K. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2022.1083760 · Cited by 23
“, vitamin C monotherapy in septic patients was associated with a significantly higher occurrence of the combined endpoint: “death + persistent organ dysfunction,” while the latter was defined as use of vasopressors, invasive mechanical ventilation, or new renal-replacement therapy at 28 days (128).”
BackgroundCellular Mechanisms of Lung Injury
Meegan, J. E., Rizzo, A. N., Schmidt, E. P., & Bastarache, J. A. (2024) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2024.08.004 · Cited by 19
Ng, P. Y., Ng, A. K., Ip, A., Wu, M., Guo, R., & Yiu, K. (2023) · Critical Care Medicine · doi:10.1097/ccm.0000000000005869 · Cited by 17
“However, recent clinical trials have failed to identify therapies that effectively moderate overall ICU and sepsis-related mortality (4, 5).”
BackgroundEffect of high-dose vitamin C on renal ischemia-reperfusion injury
Ko, S. H., Jun, J. H., Oh, J. E., Shin, E., Kwak, Y. L., & Shim, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116407 · Cited by 18
May, C. N., Ow, C. P. C., Pustovit, R. V., Lane, D. J. R., Jufar, A. H., Trask-Marino, A. L., Peiris, R. M., Gunn, A. P., Booth, L. C., Plummer, M. P., et al. (2024) · British Journal of Anaesthesia · doi:10.1016/j.bja.2024.04.058 · Cited by 17
Dvořák, Z., Li, H., & Mani, S. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.122.000860 · Cited by 16
Vitamin C as a treatment for organ failure in sepsis
Wang, Z., Liu, L., & Liu, L. (2023) · European journal of medical research · doi:10.1186/s40001-023-01183-7 · Cited by 17
“The incidence of death or permanent organ failure at day 28 was higher in the vitamin C-treated group than in the control group [40].”
BackgroundCell-free DNA in sepsis: from molecular insights to clinical management
Li, L., Huang, H., He, Y., Pang, J., Xiao, S.-C., Xia, Z., & Zheng, Y. (2025) · Military Medical Research · doi:10.1186/s40779-025-00668-2 · Cited by 22
Vandervelden, S., Cortens, B., Fieuws, S., Eegdeman, W., Malinverni, S., Vanhove, P., Monsieurs, K. G., Breuls, J., Hubloue, I., Stifkens, F., et al. (2025) · Critical Care · doi:10.1186/s13054-025-05383-x · Cited by 19
“This contrasts with the recent LOVIT trial, where serious anaphylactic reactions as well as a higher risk of death or persistent organ dysfunction at 28 days were observed in patients on vasopressor treatment receiving vitamin C [21].”
InfluentialZeng, Y., Liu, Z., Xu, F., & Tang, Z. (2023) · Medicine · doi:10.1097/md.0000000000035648 · Cited by 16
“[9,10] Forest plots showed that high-dose vitamin C therapy did not significantly ( 16 ) 10 ( 12 ) 54 ( 65 ) L v 202 1 [ 16 ] I n t e r v e n t i o n 58 .”
BackgroundMethodInfluentialMaity, J., Majumder, S., Pal, R., Saha, B., & Mukhopadhyay, P. K. (2023) · BioEssays · doi:10.1002/bies.202300035 · Cited by 16
“[126] Intravenous vitamin C has a higher risk of death or persistent organ dysfunction in adults with sepsis receiving vasopressor therapy.[127] In individuals with septic shock, ascorbic acid monotherapy was unable to reduce mortality.”
Cook, D. J., Taneja, S., Krewulak, K. D., Zytaruk, N. L., Menon, K., Fowler, R., Lamontagne, F., Kho, M. E., Rochwerg, B. N., Masse, M.-H., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.20458 · Cited by 15
Self-citationWayland, J., Teixeira, J. P., & Nielsen, N. D. (2024) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2024.06.010 · Cited by 23
Marmiere, M., D’Amico, F., Monti, G., & Landoni, G. (2024) · Critical Care Medicine · doi:10.1097/ccm.0000000000006532 · Cited by 18
Intravenous vitamin C in adults with sepsis in the intensive care unit: still LOV’IT?
Stoppe, C., Preiser, J., Backer, D. D., & Elke, G. (2022) · Critical Care · doi:10.1186/s13054-022-04106-w · Cited by 16
“As opposed to placebo, vitamin C was associated with an increased occurrence of the primary endpoint (persistent organ dysfunction plus death) [1].”
BackgroundChen, C.-Y., Chiu, C.-T., Lee, H.-S., & Lai, C. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.11.015 · Cited by 15
Interpreting frequentist hypothesis tests: insights from Bayesian inference
Sidebotham, D. A., Barlow, C. J., Martin, J. E., & Jones, P. M. (2023) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-023-02557-5 · Cited by 18
Cao, X., Yi, Y., Ji, M., Liu, Y., Wang, D., & Zhu, H. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1633447 · Cited by 15
Liu, C., Cai, Y., Ma, Q., & Sun, W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1731995 · Cited by 15
“Network meta-analyses further indicate marked variation in dosing, treatment duration, and co-administration regimens with thiamine and corticosteroids, rendering conclusions regarding long-term mortality both non-robust and highly heterogeneous (193, 194).”
The Response of Macrophages in Sepsis-Induced Acute Kidney Injury
He, J., Zhao, S. T., & Duan, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12031101 · Cited by 18
“In addition, macrophage-based nanoparticles have also been used in the treatment of SAKI [68].”
MethodLi, W., Zhao, R., Liu, S., Ma, C., & Wan, X. (2024) · Medicine · doi:10.1097/md.0000000000037838 · Cited by 14
Raman, S., GIBBONS, K. S., Jayashree, M., Lalitha, A. V., Bellomo, R., Blythe, R. D., Buckley, D. H. F., Butt, W. W., Cho, H. J., Cree, M., et al. (2024) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000003674 · Cited by 13
Xu, C., Yi, T., Tan, S., Xu, H., Hu, Y., Ma, J., & Xu, J. (2023) · Nutrients · doi:10.3390/nu15081848 · Cited by 14
Eligibility Criteria of Randomized Clinical Trials in Critical Care Medicine
Heirali, A., Heybati, K., Sereeyotin, J., Khan, F. A., Yarnell, C. J., Krewulak, K. D., Murthy, S., Burns, K. E. A., Fowler, R., Fiest, K. M., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.54944 · Cited by 15
Self-citationCausal effects of genetically vitamins and sepsis risk: a two-sample Mendelian randomization study
Lou, C., Meng, Z., Shi, Y., Zheng, R., Pan, J., & Qian, S. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08778-9 · Cited by 12
“Within 28 days, patients who with sepsis receiving vasopressor therapy in the ICU are more likely to die or experience organ dysfunction after intravenous vitamin C injection [8].”
Background
Metadata
- Authors
- Lamontagne, F., Masse, M.-H., Menard, J., Sprague, S., Pinto, R., Heyland, D. K., Cook, D. J., Battista, M.-C., Day, A. G., Guyatt, G. H., Kanji, S., Parke, R., McGuinness, S. P., Tirupakuzhi Vijayaraghavan, B.-K., Annane, D., Cohen, D., Arabi, Y. M., Bolduc, B., Marinoff, N., Rochwerg, B., Millen, T., Meade, M. O., Hand, L., Watpool, I., Porteous, R., Young, P. J., D’Aragon, F., Belley-Cote, E. P., Carbonneau, E., Clarke, F., Maslove, D. M., Hunt, M., Chassé, M., Lebrasseur, M., Lauzier, F., Mehta, S., Quiroz-Martinez, H., Rewa, O. G., Charbonney, E., Seely, A. J. E., Kutsogiannis, D. J., LeBlanc, R., Mekontso-Dessap, A., Mele, T. S., Turgeon, A. F., Wood, G., Kohli, S. S., Shahin, J., Twardowski, P., & Adhikari, N. K. J.
- Affiliations
- Université de Sherbrooke (CA)
- Centre Hospitalier Universitaire de Sherbrooke (CA)
- Research Centre of the Centre hospitalier universitaire de Sherbrooke, Sherbrooke, QC, Canada J1H 5N4
- McMaster University (CA)
- Sunnybrook Health Science Centre (CA)
- Queen's University (CA)
- St. Joseph’s Healthcare Hamilton (CA)
- Ottawa Hospital (CA)
- University of Auckland (NZ)
- Auckland City Hospital (NZ)
- Department of Critical Care Medicine, Apollo Hospitals, Chennai, India
- Inserm (FR)
- Bishop's University (CA)
- King Saud bin Abdulaziz University for Health Sciences (SA)
- Juravinski Hospital (CA)
- Hamilton Health Sciences (CA)
- Ottawa Hospital Research Institute (CA)
- Apollo Hospitals (IN)
- McMaster University, Department of Medicine, Hamilton, ON, Canada L8N 3Z5
- Centre Hospitalier de l’Université de Montréal (CA)
- Université Laval (CA)
- University of Toronto (CA)
- University of Alberta (CA)
- Hôpital du Sacré-Cœur de Montréal (CA)
- University of Ottawa (CA)
- Université de Sherbrooke, Department of Medicine, Sherbrooke, QC, Canada J1H 5N4
- AP-HP, Hôpitaux Universitaires Henri-Mondor, Service de Médecine Intensive Réanimation Creteil, Île-de-France, FR 94000
- Western University (CA)
- Island Health (CA)
- McGill University Health Centre (CA)
- University of Otago, Department of Surgical Sciences, Dunedin, NZ 9054
- ORCID
- Lamontagne, François
- Masse, Marie-Hélène
- Sprague, Sheila
- Pinto, Ruxandra
- Heyland, Daren K.
- Battista, Marie-Claude
- Day, Andrew G.
- Guyatt, Gordon H.
- Kanji, Salmaan
- Parke, Rachael
- McGuinness, Shay P.
- Annane, Djillali
- Cohen, Dian
- Arabi, Yaseen M.
- Rochwerg, Bram
- Meade, Maureen O.
- Watpool, Irene
- Porteous, Rebecca
- Young, Paul J.
- Clarke, France
- Maslove, David M.
- Chassé, Michaël
- Lauzier, François
- Mehta, Sangeeta
- Rewa, Oleksa G.
- Charbonney, Emmanuel
- Seely, Andrew J.E.
- Kutsogiannis, Demetrios J.
- Mele, Tina S.
- Turgeon, Alexis F.
- Wood, Gordon
- Shahin, Jason
- Adhikari, Neill K.J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2022-06-23
- Volume
- 386
- Issue
- 25
- Pages
- 2387-2398
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4282975062
- Cited by
- 350
- References
- 31
- Citations by year
- 2026: 58 · 2025: 79 · 2024: 75 · 2023: 98 · 2022: 40
- FWCI
- 45.02
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- The Lotte & John Hecht Memorial Foundation (4318)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Vitamin C and Antioxidants Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
- Keywords
- intravenous vitamin C, vitamin C, vasopressor therapy, intensive care unit, mortality, organ dysfunction, acute kidney injury, hypoglycemia, anaphylaxis, sepsis treatment, critically ill adults, health-related quality of life, 6-month survival, biomarkers, organ dysfunction scores
- MeSH terms
- Adult, Ascorbic Acid, Humans, Hypoglycemic Agents, Intensive Care Units, Multiple Organ Failure, Quality of Life, Vasoconstrictor Agents, Vitamins, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.